Octagon Capital Advisors LP 13D and 13G filings for ArriVent BioPharma, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-11 4:02 pm Purchase |
2024-09-30 | 13G | ArriVent BioPharma, Inc. Common Stock AVBP |
Octagon Capital Advisors LP | 1,976,387 5.900% |
1,976,387 (New Position) |
Filing |